Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

19.83

-1.18 (-5.62%)

At close: Mar 3, 2026, 4:00 PM EST

20.34

+0.51 (2.57%)

After-hours: Mar 3, 2026, 7:01 PM EST

Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	170.18	151.61	144.3	156.1	126.35
Short-Term Investments	112.64	70.04	112.51	19.66	10.32
Cash & Short-Term Investments	282.81	221.65	256.81	175.76	136.67
Cash Growth	27.60%	-13.69%	46.11%	28.60%	29.40%
Accounts Receivable	143.56	136.29	114.94	88.8	78.8
Other Receivables	17.17	1.75	0.53	0.17	0.13
Receivables	160.73	138.04	115.47	88.98	78.93
Inventory	176.89	153.74	105.83	103.58	92.81
Prepaid Expenses	13.15	18.21	9.06	7.56	7.27
Restricted Cash	0.24	0.24	0.24	0.24	0.24
Other Current Assets	2.2	2.2	2.2	2.2	2.2
Total Current Assets	636.02	534.07	489.6	378.32	318.12
Property, Plant & Equipment	353.72	344.63	315.64	264.57	271.49
Long-Term Investments	-	11	15.21	2.41	3.99
Goodwill	3.4	3.05	3.22	3.13	3.31
Other Intangible Assets	562.56	587.61	610.08	34.17	35.56
Long-Term Deferred Tax Assets	42.46	71.12	53.25	38.53	22.4
Other Long-Term Assets	31.14	25.99	25.91	20.86	16.67
Total Assets	1,629	1,577	1,513	741.99	671.53
Accounts Payable	32.59	30.51	25.44	20.5	22.21
Accrued Expenses	96.76	103.1	54.75	46.19	44.17
Current Portion of Long-Term Debt	1.47	0.23	0.44	3.05	2.2
Current Portion of Leases	8.1	6.8	3.91	3	2.98
Current Income Taxes Payable	0.24	9.66	1.61	4.57	9.08
Other Current Liabilities	19	23.44	139.27	17.55	23.16
Total Current Liabilities	158.16	173.76	225.41	94.86	103.81
Long-Term Debt	608.66	601.2	588.96	72.84	74.38
Long-Term Leases	37.77	42.31	30.34	23.69	25.1
Pension & Post-Retirement Benefits	2.6	2.6	2.6	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.14	0.53
Other Long-Term Liabilities	33.31	25.3	26.18	21.79	22.18
Total Liabilities	840.49	845.17	873.49	213.33	226.01
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	535.38	505.4	486.06	455.08	422.42
Retained Earnings	666.88	568.79	409.27	271.72	180.34
Treasury Stock	-408.15	-332.71	-247.43	-189.52	-150.48
Comprehensive Income & Other	-5.31	-9.18	-8.48	-8.62	-6.77
Total Common Equity	788.81	732.3	639.42	528.66	445.52
Shareholders' Equity	788.81	732.3	639.42	528.66	445.52
Total Liabilities & Equity	1,629	1,577	1,513	741.99	671.53
Total Debt	656	650.55	623.64	102.58	104.66
Net Cash (Debt)	-373.19	-428.9	-366.84	73.18	32.01
Net Cash Growth	-	-	-	128.62%	-16.53%
Net Cash Per Share	-7.74	-8.24	-6.92	1.40	0.64
Filing Date Shares Outstanding	45.37	47.65	48.1	47.9	48.15
Total Common Shares Outstanding	45.65	47.62	48.07	48.11	47.71
Working Capital	477.86	360.31	264.19	283.46	214.31
Book Value Per Share	17.28	15.38	13.30	10.99	9.34
Tangible Book Value	222.84	141.64	26.13	491.36	406.65
Tangible Book Value Per Share	4.88	2.97	0.54	10.21	8.52
Land	7.55	7.42	7.48	7.45	7.62
Buildings	196.68	169.43	168.77	130.73	130.58
Machinery	342.1	313.38	291.43	237.74	235.26
Construction In Progress	24.41	36.69	18.68	50.84	41.19
Leasehold Improvements	46.1	42.01	41.69	31.54	29.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q